Exclusion Criteria:~1. Patient has had a myocardial infarction, unstable angina, stroke, transient ischemic
attack or required intervention for any of these conditions (e.g., coronary artery bypass graft, percutaneous
coronary intervention via cardiac catheterization, thrombolytic therapy) within 6 months of the Screening
Visit;~2. Has other neurological disorders, including vascular dementia, Parkinson's disease, frontotemporal
dementia, Huntington's disease, amyotrophic lateral sclerosis, multiple sclerosis, progressive supranuclear
palsy, neurosyphilis, dementia with Lewy bodies, other types of dementia, mental retardation, hypoxic cerebral
damage, and cognitive impairment from head trauma;~3. Scheduled or anticipates vaccination with a live vaccine
during the study;~4. Current use of a cannabidiol or derivative;~5. Current use of digoxin;~6. Acute or chronic
liver disease;~7. AST \&gt;1.5 times the Upper Limit of Normal~8. ALT \&gt; 1.5 times the Upper Limit of
Normal~9. Schizophrenia, bipolar disorder, suicidal ideation, major depression, or delirium; Note: Stable
(\&gt;2 years) treated depression without suicidal ideation is acceptable;~10. Current therapy with a
tetracycline;~11. Current therapy with sirolimus or a rapalog macrolide antibiotic;~12. Known allergies to any
of the active drugs: tetracycline antibiotics, rapalog macrolide antibiotics, or statin therapies;~13.
Treatment with another investigational drug, device, or intervention within 30 days prior to the Screening
Visit;
